Shenzhen Hwagen Pharmaceutical

CAS 20191-74-6

Chemistry, 1 End Use API, 34 Related Intermediates

Manufacturers/Suppliers

1 Suppliers

1 Suppliers

Also known as: 20191-74-6, 2-ethyl-5-nitrobenzenamine, 2-ethyl-5-nitrobenzenamine ,98%, Mfcd00034056, En300-108913, Benzenamine, 2-ethyl-5-nitro-

Molecular Formula

C₈H₁₀N₂O₂

Molecular Weight

166.18 g/mol

InChI Key

MMZWMCKTKJKIMC-UHFFFAOYSA-N

1 2D Structure

CAS 20191-74-6

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-ethyl-5-nitroaniline

2.1.2 InChI

InChI=1S/C8H10N2O2/c1-2-6-3-4-7(10(11)12)5-8(6)9/h3-5H,2,9H2,1H3

2.1.3 InChI Key

MMZWMCKTKJKIMC-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCC1=C(C=C(C=C1)[N+](=O)[O-])N

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 20191-74-6

2. 2-ethyl-5-nitrobenzenamine

3. 2-ethyl-5-nitrobenzenamine ,98%

4. Mfcd00034056

5. En300-108913

6. Benzenamine, 2-ethyl-5-nitro-

7. 2-ethyl-5-nitro-benzenamine

8. 2-ethyl-5-nitro-phenylamine

9. Schembl588348

10. 4-nitro-2-amino-1-ethylbenzene

11. Dtxsid00400021

12. Mmzwmcktkjkimc-uhfffaoysa-n

13. Bdbm625975

14. Amy21006

15. Bcp18607

16. Akos015890562

17. Ds-5221

18. Ac-27055

19. Sy017465

20. A4400

21. Cs-0012535

22. E1085

23. Ft-0687652

24. J-509323

25. 64694-19-5

2.3 Create Date

2005-09-13

3 Chemical and Physical Properties

Molecular Formula	C₈H₁₀N₂O₂
Molecular Weight	166.18 g/mol
XLogP3	2.3
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	1
Exact Mass	g/mol
Monoisotopic Mass	g/mol
Topological Polar Surface Area	71.8
Heavy Atom Count	12
Formal Charge	0
Complexity	167
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

6-[N-(2-chloropyrimidin-4-yl)amino]-2,3-dimethyl-2H-ind...

PDF Supplier PDF

URL Supplier Web Content

CAS Number

444731-74-2

End Use API

Pazopanib Hydrochloride

About the Company

Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leader...

Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leadership of a “National 1000 Talents Program” expert. By leveraging its core competency in chiral synthesis, enzymatic catalysis and continuous flow micro reactor, HwaGen Pharmaceutical is dedicated to development and manufacturing of specialty and niche intermediates and APIs covering various therapeutic areas including oncology, antiviral and respiratory, delivering high value-added and affordable products for global pharmaceutical industry. Equipments for Analysis & Test include Tabletop NMR, LC-MS, GC, HPLC etc.

ASK
US